Summary
Global Market Direct’s pharmaceuticals report, “Penwest Pharmaceuticals - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the company’s future therapy areas of focus.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.
Scope
- Penwest Pharmaceuticals - company overview including business description, key employees, and other facts.
- Review of current pipeline of Penwest Pharmaceuticals human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of Penwest Pharmaceuticals with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of the Penwest Pharmaceuticals’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Penwest Pharmaceuticals’s strategic position with total access to a detailed intelligence on its product pipeline.
- Assess the growth potential of Penwest Pharmaceuticals in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Penwest Pharmaceuticals’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Penwest Pharmaceuticals.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Penwest Pharmaceuticals and identify potential opportunities in those areas.
- Do deals with an understanding of the mergers and partnerships that have shaped the sector.
Global Market Direct’s pharmaceuticals report, “Penwest Pharmaceuticals - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the company’s future therapy areas of focus.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.
Scope
- Penwest Pharmaceuticals - company overview including business description, key employees, and other facts.
- Review of current pipeline of Penwest Pharmaceuticals human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of Penwest Pharmaceuticals with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of the Penwest Pharmaceuticals’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Penwest Pharmaceuticals’s strategic position with total access to a detailed intelligence on its product pipeline.
- Assess the growth potential of Penwest Pharmaceuticals in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Penwest Pharmaceuticals’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Penwest Pharmaceuticals.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Penwest Pharmaceuticals and identify potential opportunities in those areas.
- Do deals with an understanding of the mergers and partnerships that have shaped the sector.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 list of Figures
2 INTRODUCTION
3 PENWEST PHARMACEUTICALS SNAPSHOT
3.1 Business Description
4 PENWEST PHARMACEUTICALS- RESEARCH AND DEVELOPMENT OVERVIEW
4.1 Key Therapeutic Areas
5 PENWEST PHARMACEUTICALS- PIPELINE REVIEW
5.1 Pipeline Products by Stage of Development
5.2 Pipeline Products-Monotherapy
5.3 Pipeline Products-Combination Treatment Modalities
6 PENWEST PHARMACEUTICALS PIPELINE PRODUCTS GLANCE
6.1 Penwest Pharmaceuticals Phase II Pipeline
6.2 Penwest Pharmaceuticals Phase I Pipeline
6.3 Penwest Pharmaceuticals Pre-Clinical Pipeline
7 PENWEST PHARMACEUTICALS - DRUG PROFILES
7.1 Product
7.1.1 Product Description
7.1.2 Mechanism of Action
7.1.3 R&D Progress
8 PENWEST PHARMACEUTICALS PIPELINE ANALYSIS
8.1 Penwest Pharmaceuticals Pipeline Products by Therapeutic Class
8.2 Penwest Pharmaceuticals Pipeline Products by Target
8.3 Penwest Pharmaceuticals Pipeline by Route of Administration
8.4 Penwest Pharmaceuticals Pipeline Products by Molecule Type
9 PENWEST PHARMACEUTICALS- RECENT PIPELINE UPDATES
10 PENWEST PHARMACEUTICALS- DORMANT PIPELINE PROJECTS
10.1 Feature on Dormant Projects
11 PENWEST PHARMACEUTICALS- DISCONTINUED PIPELINE PRODUCTS
11.1 Discontinued Pipeline Product Profiles
11.1.1 Product
12 PENWEST PHARMACEUTICALS – FEATURED NEWS
13 PENWEST PHARMACEUTICALS STATEMENT
13.1 Penwest Pharmaceuticals - Locations and Subsidiaries
14 APPENDIX
14.1 Global Markets Direct Research Methodology
14.2 Coverage
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Expert Panels
14.7 Contact Us
14.8 Disclaimer
LIST OF TABLES
Table 1: Penwest Pharmaceuticals - Key Information
Table 2: Penwest Pharmaceuticals - Key Facts
Table 3: Penwest Pharmaceuticals - Key Therapeutic Areas
Table 4: Penwest Pharmaceuticals - Pipeline by Stage of Development,
Table 5: Penwest Pharmaceuticals - Monotherapy Products in Pipeline,
Table 6: Penwest Pharmaceuticals - Combination Treatment Modalities in Pipeline,
Table 7: Penwest Pharmaceuticals - Phase II Pipeline,
Table 8: Penwest Pharmaceuticals - Phase I Pipeline,
Table 9: Penwest Pharmaceuticals - Pre-Clinical Pipeline,
Table 10: Penwest Pharmaceuticals - Pipeline By Therapeutic Class
Table 11: Penwest Pharmaceuticals - Pipeline By Target
Table 12: Penwest Pharmaceuticals - Pipeline By Route of Administration
Table 13: Penwest Pharmaceuticals - Pipeline By Molecule Type
Table 14: Penwest Pharmaceuticals - recent Pipeline Updates
Table 15: Penwest Pharmaceuticals - Dormant Pipeline Projects
LIST OF FIGURES
Figure 1: Penwest Pharmaceuticals - Research and Development Overview
Figure 2: Penwest Pharmaceuticals - Pipeline by Stage of Development,
Figure 3: Penwest Pharmaceuticals - Monotherapy Products in Pipeline,
Figure 4: Penwest Pharmaceuticals - Combination Treatment Modalities in Pipeline,
Figure 5: Penwest Pharmaceuticals - Pipeline By Therapeutic Class and Stage of Development
Figure 6: Penwest Pharmaceuticals - Pipeline By Therapeutic Class
Figure 7: Penwest Pharmaceuticals - Pipeline By Target and Stage of Development
Figure 8: Penwest Pharmaceuticals - Pipeline By Target
Figure 9: Penwest Pharmaceuticals - Pipeline By Route of Administration and Stage of Development
Figure 10: Penwest Pharmaceuticals - Pipeline By Route of Administration
Figure 11: Penwest Pharmaceuticals - Pipeline By Molecule Type and Stage of Development
Figure 12: Penwest Pharmaceuticals - Pipeline By Molecule Type
COMPANIES MENTIONED
Penwest Pharmaceuticals
1.1 List of Tables
1.2 list of Figures
2 INTRODUCTION
3 PENWEST PHARMACEUTICALS SNAPSHOT
3.1 Business Description
4 PENWEST PHARMACEUTICALS- RESEARCH AND DEVELOPMENT OVERVIEW
4.1 Key Therapeutic Areas
5 PENWEST PHARMACEUTICALS- PIPELINE REVIEW
5.1 Pipeline Products by Stage of Development
5.2 Pipeline Products-Monotherapy
5.3 Pipeline Products-Combination Treatment Modalities
6 PENWEST PHARMACEUTICALS PIPELINE PRODUCTS GLANCE
6.1 Penwest Pharmaceuticals Phase II Pipeline
6.2 Penwest Pharmaceuticals Phase I Pipeline
6.3 Penwest Pharmaceuticals Pre-Clinical Pipeline
7 PENWEST PHARMACEUTICALS - DRUG PROFILES
7.1 Product
7.1.1 Product Description
7.1.2 Mechanism of Action
7.1.3 R&D Progress
8 PENWEST PHARMACEUTICALS PIPELINE ANALYSIS
8.1 Penwest Pharmaceuticals Pipeline Products by Therapeutic Class
8.2 Penwest Pharmaceuticals Pipeline Products by Target
8.3 Penwest Pharmaceuticals Pipeline by Route of Administration
8.4 Penwest Pharmaceuticals Pipeline Products by Molecule Type
9 PENWEST PHARMACEUTICALS- RECENT PIPELINE UPDATES
10 PENWEST PHARMACEUTICALS- DORMANT PIPELINE PROJECTS
10.1 Feature on Dormant Projects
11 PENWEST PHARMACEUTICALS- DISCONTINUED PIPELINE PRODUCTS
11.1 Discontinued Pipeline Product Profiles
11.1.1 Product
12 PENWEST PHARMACEUTICALS – FEATURED NEWS
13 PENWEST PHARMACEUTICALS STATEMENT
13.1 Penwest Pharmaceuticals - Locations and Subsidiaries
14 APPENDIX
14.1 Global Markets Direct Research Methodology
14.2 Coverage
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Expert Panels
14.7 Contact Us
14.8 Disclaimer
LIST OF TABLES
Table 1: Penwest Pharmaceuticals - Key Information
Table 2: Penwest Pharmaceuticals - Key Facts
Table 3: Penwest Pharmaceuticals - Key Therapeutic Areas
Table 4: Penwest Pharmaceuticals - Pipeline by Stage of Development,
Table 5: Penwest Pharmaceuticals - Monotherapy Products in Pipeline,
Table 6: Penwest Pharmaceuticals - Combination Treatment Modalities in Pipeline,
Table 7: Penwest Pharmaceuticals - Phase II Pipeline,
Table 8: Penwest Pharmaceuticals - Phase I Pipeline,
Table 9: Penwest Pharmaceuticals - Pre-Clinical Pipeline,
Table 10: Penwest Pharmaceuticals - Pipeline By Therapeutic Class
Table 11: Penwest Pharmaceuticals - Pipeline By Target
Table 12: Penwest Pharmaceuticals - Pipeline By Route of Administration
Table 13: Penwest Pharmaceuticals - Pipeline By Molecule Type
Table 14: Penwest Pharmaceuticals - recent Pipeline Updates
Table 15: Penwest Pharmaceuticals - Dormant Pipeline Projects
LIST OF FIGURES
Figure 1: Penwest Pharmaceuticals - Research and Development Overview
Figure 2: Penwest Pharmaceuticals - Pipeline by Stage of Development,
Figure 3: Penwest Pharmaceuticals - Monotherapy Products in Pipeline,
Figure 4: Penwest Pharmaceuticals - Combination Treatment Modalities in Pipeline,
Figure 5: Penwest Pharmaceuticals - Pipeline By Therapeutic Class and Stage of Development
Figure 6: Penwest Pharmaceuticals - Pipeline By Therapeutic Class
Figure 7: Penwest Pharmaceuticals - Pipeline By Target and Stage of Development
Figure 8: Penwest Pharmaceuticals - Pipeline By Target
Figure 9: Penwest Pharmaceuticals - Pipeline By Route of Administration and Stage of Development
Figure 10: Penwest Pharmaceuticals - Pipeline By Route of Administration
Figure 11: Penwest Pharmaceuticals - Pipeline By Molecule Type and Stage of Development
Figure 12: Penwest Pharmaceuticals - Pipeline By Molecule Type
COMPANIES MENTIONED
Penwest Pharmaceuticals